Vaxcyte, Inc. (NASDAQ:PCVX) Secures U.S. Fill‑Finish Pact, Tightening Commercial Readiness
Momentum in manufacturing partnerships and constructive short-term technicals point toward a near-term positive bias for the stock. Fundamental strength in liquidity contrasts with ongoing operating losses and negative free cash flow.







